rdf:type |
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0036525,
umls-concept:C0085862,
umls-concept:C0087111,
umls-concept:C0205146,
umls-concept:C0681890,
umls-concept:C1274040,
umls-concept:C1299583,
umls-concept:C1522484,
umls-concept:C1527249,
umls-concept:C1549571,
umls-concept:C1563740,
umls-concept:C1608386
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-3-8
|
pubmed:abstractText |
Adipose tissue releases angiogenic factors that may promote tumour growth.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1468-3288
|
pubmed:author |
pubmed-author:BonnetainFranckF,
pubmed-author:BorgChristopheC,
pubmed-author:CercueilJean-PierreJP,
pubmed-author:ChauffertBrunoB,
pubmed-author:GhiringhelliFrançoisF,
pubmed-author:GuiuBorisB,
pubmed-author:GuiuSéverineS,
pubmed-author:HillonPatrickP,
pubmed-author:KrauséDenisD,
pubmed-author:LadoireSylvainS,
pubmed-author:PetitJean MichelJM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
341-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:19837679-Adenocarcinoma,
pubmed-meshheading:19837679-Adult,
pubmed-meshheading:19837679-Aged,
pubmed-meshheading:19837679-Aged, 80 and over,
pubmed-meshheading:19837679-Angiogenesis Inhibitors,
pubmed-meshheading:19837679-Antibodies, Monoclonal,
pubmed-meshheading:19837679-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:19837679-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19837679-Body Mass Index,
pubmed-meshheading:19837679-Colorectal Neoplasms,
pubmed-meshheading:19837679-Disease Progression,
pubmed-meshheading:19837679-Female,
pubmed-meshheading:19837679-Humans,
pubmed-meshheading:19837679-Intra-Abdominal Fat,
pubmed-meshheading:19837679-Male,
pubmed-meshheading:19837679-Middle Aged,
pubmed-meshheading:19837679-Prognosis,
pubmed-meshheading:19837679-Retrospective Studies,
pubmed-meshheading:19837679-Subcutaneous Fat,
pubmed-meshheading:19837679-Survival Analysis,
pubmed-meshheading:19837679-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
|
pubmed:affiliation |
Department of Radiology, Georges-Francois Leclerc Cancer Cente, Dijon, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|